Search results
Author(s):
Antoni Martínez-Rubio
,
Mario DiazNuila-Alcazar
,
Anna Soria Cadena
,
et al
Added:
3 years ago
Atrial fibrillation (AF) is the most commonly encountered arrhythmia in clinical practice in Western countries. The prevalence of AF depends on the population studied1 and especially on age.2–9 It is affected by increasing longevity and is modulated by the prevalence of cardiovascular risk factors, especially arterial hypertension and related habits. In Spain, for example, the prevalence of AF…
View more
Author(s):
Daniel TT Chong
,
Felicita Andreotti
,
Peter Verhamme
,
et al
Added:
2 years ago
Author(s):
Gautam R Shroff
,
Michelle D Carlson
,
Roy O Mathew
Added:
2 years ago
Author(s):
Yukiko Isekame
,
Sabiha Gati
,
Jose Antonio Aragon-Martin
,
et al
Added:
3 years ago
Marfan syndrome (MFS) is a disease in which connective tissue becomes weak secondary to fibrillin-1 mutations, resulting in aortic dilatation, aneurysm formation, aortic dissection, aortic regurgitation and mitral valve prolapse (MVP; see Table 1).
Epidemiology
MFS is an autosomal dominant condition: 75 % of all patients inherit the condition from one affected parent and 25 % are affected as…
View more
Author(s):
Lee Chang
,
Robert Yeh
Added:
3 years ago
Cardiogenic shock is the leading cause of death in patients with acute ST-elevation myocardial infarction (STEMI). Characterised by a state of low cardiac output leading to end-organ hypoperfusion, cardiogenic shock complicates approximately 5–8 % of STEMIs and is associated with a mortality rate approaching 50 percent.1–3 Prompt recognition and therapeutic intervention for cardiogenic shock due…
View more
Author(s):
Paolo Colonna
Added:
4 years ago
Dr Paolo Colonna (Cardiology Department, Policlinico of Bari Hospital, Bari, IT) discusses the EMIT AF/VTE study, which investigates if periprocedural edoxaban management in routine clinical practice is associated with lower bleeding risk.
Filmed on site at EHRA 2019 by Radcliffe Cardiology.
Questions:
1. What is the aim of this study?
2. What is the design of the registry and edoxaban dosing…
View more
Author(s):
Gabriel Torres-Ruiz
,
Nuria Mallofré-Vila
,
Paola Rojas-Flores
,
et al
Added:
3 months ago
Author(s):
Kevin Cheng
,
Ranil de Silva
Added:
3 years ago
Refractory angina (RA) is defined as chronic angina-type chest pain (duration ≥ 3 months) associated with reversible ischaemia that persists despite optimal medical, interventional and surgical management.1
The clinical burden of RA is growing due to an ageing population and improved survival from coronary artery disease (CAD). Estimates suggest that in the US between 600,000 and 1.8 million…
View more
PCI Outcomes in Women
Author(s):
Antonia Sambola
,
Bruno García Del Blanco
,
Vijay Kunadian
,
et al
Added:
1 year ago
Article
Author(s):
Antonio FB de Azevedo Filho
,
Tarso AD Accorsi
,
Henrique B Ribeiro
Added:
2 years ago